BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...

The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted BioCity's ...

BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD ...

Topline data also show that lorundrostat reduces albuminuria in hypertensive patients with CKD. Topline results from the phase 2 Explore-CKD trial show lorundrostat, an aldosterone synthase ...

BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...

Smartphone-based home screening significantly boosts chronic kidney disease (CKD) diagnosis and follow-up care, enhancing ...

Mineralys Therapeutics announced positive topline results from its phase 2 Explore-CKD trial, in which lorundrostat lowered ...

Clinicians and their patients with chronic kidney disease (CKD) need to be aware of zinc intake and anemia status.

Tom Nolan reviews this week’s research A diagnostic accuracy study of a blood test for colorectal cancer has some promising, if paradoxical, findings. The cell free DNA test had an overall sensitivity ...